Difficulty: Medium
Average Score: 94%
Practice
A patient has been receiving epoetin alfa (Epogen) for severe iron-deficiency anemia. Today, the provider changed the order to darbepoetin (Aranesp). The patient questions the nurse, ÔÇ£What is the difference in these drugs?ÔÇØ Which response by the nurse is correct?
Correct answer
D
Rationale
The correct answer is D: ÔÇ£Aranesp is a longer-acting form, so you will receive fewer injections.ÔÇØ
Rationale:
1. Darbepoetin (Aranesp) is a longer-acting form of erythropoietin compared to epoetin alfa (Epogen).
2. Due to its extended half-life, Aranesp requires less frequent dosing, leading to fewer injections for the patient.
3. This is beneficial for patient compliance and convenience, as they don't have to undergo frequent injections.
4. Choice A is incorrect because there is a difference between the two drugs in terms of pharmacokinetics.
5. Choice B is incorrect as the speed of action is not the primary difference between the two drugs.
6. Choice C is incorrect because Aranesp, like Epogen, is administered via injections, not orally.
Rationale:
1. Darbepoetin (Aranesp) is a longer-acting form of erythropoietin compared to epoetin alfa (Epogen).
2. Due to its extended half-life, Aranesp requires less frequent dosing, leading to fewer injections for the patient.
3. This is beneficial for patient compliance and convenience, as they don't have to undergo frequent injections.
4. Choice A is incorrect because there is a difference between the two drugs in terms of pharmacokinetics.
5. Choice B is incorrect as the speed of action is not the primary difference between the two drugs.
6. Choice C is incorrect because Aranesp, like Epogen, is administered via injections, not orally.